FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion March 27, 2017 FDA Clears Massachusetts Biotech Tesaro's Ovarian Cancer PARP Inhibitor March 27, 2017 SomaGenics Inc. Awarded NIH Funding To Develop NGS Single-Cell Analysis Of Small RNAs October 9, 2017
Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion March 27, 2017
SomaGenics Inc. Awarded NIH Funding To Develop NGS Single-Cell Analysis Of Small RNAs October 9, 2017
